There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.
The present invention provides a composition comprising a combination of components A) and B), wherein component A) is a compound of formula (I) and the component (B) is a further fungicide, insecticide or herbicide.
The present invention provides a composition comprising a combination of components A) and B), wherein component A) is a compound of formula (I) and the component (B) is a further fungicide, insecticide or herbicide.
ELECTROLYTE SOLUTION FOR DYE SENSITIZED SOLAR CELL, AND DYE SENSITIZED SOLAR CELL USING SAME
申请人:Chiba Kazumi
公开号:US20120301992A1
公开(公告)日:2012-11-29
It is to provide an electrolyte solution for a dye sensitized solar cell that does not generate a gas, can be used in a wide temperature range, and is excellent in durability. The electrolyte solution contains a chain sulfone compound represented by formula (1) as a solvent. (In the formula, R
1
and R
2
each independently represent an alkyl group having from 1 to 12 carbon atoms, which may be partially substituted by a halogen, an alkoxy group or an aromatic ring, an alkoxy group, or a phenyl group.)